Solventum Corporation (SOLV) EV/FCF Ratio: N/A
The EV/FCF ratio for Solventum Corporation (SOLV) is N/A as of Friday, June 12, 2026.
SOLV EV/FCF Ratio Chart
SOLV Average EV/FCF Ratio Chart
SOLV EV/FCF Ratio Metrics
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
157.09x
EV/FCF RATIO AVG 3Y
88.54x
EV/FCF RATIO AVG 5Y
88.54x
EV/FCF RATIO AVG 10Y
88.54x
EV/FCF RATIO AVG 15Y
88.54x
EV/FCF RATIO AVG 20Y
88.54x
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SOLV Competitors' EV/FCF Ratio
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $13.72B | N/A | 157.09x | 88.54x | 88.54x |
| Align Technology, Inc. (ALGN) | $12.64B | 17.00x | 17.71x | 29.57x | 38.92x |
| Baxter International Inc. (BAX) | $10.58B | 25.52x | 67.89x | 51.66x | 47.33x |
| Hologic, Inc. (HOLX) | $16.97B | 17.53x | 16.89x | 18.61x | 15.13x |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 30.85x | 21.28x | 29.09x | 35.22x |
| Tempus AI, Inc. (TEM) | $8.65B | N/A | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO) | $7.91B | 24.51x | 25.10x | 43.45x | 51.09x |
| Moderna, Inc. (MRNA) | $19.70B | N/A | 26.90x | 26.23x | 26.23x |
| Hims & Hers Health, Inc. (HIMS) | $6.19B | 95.71x | 83.15x | 71.58x | 71.58x |
| BioNTech SE (BNTX) | $22.39B | 7.12x | 22.05x | 6.21x | 11.27x |
Cash Flow Valuation Comparison
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
- EV/FCF accounts for debt and cash through enterprise value
- P/FCF only considers equity value
- EV/FCF can be compared across companies with different debt levels
- Both measure how the market values cash generation
Solventum Corporation EV/FCF Ratio Formula & Definition
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Solventum Corporation EV/FCF Ratio FAQ
- What is the EV/FCF ratio for Solventum Corporation (SOLV)?
- The EV/FCF ratio for SOLV stock is N/A.
- What is the TTM average EV/FCF ratio for Solventum Corporation (SOLV)?
- The TTM average EV/FCF ratio for SOLV stock is 157.09x.
- What is the 3Y average EV/FCF ratio for Solventum Corporation (SOLV)?
- The 3Y average EV/FCF ratio for SOLV stock is 88.54x.
- What is the 5Y average EV/FCF ratio for Solventum Corporation (SOLV)?
- The 5Y average EV/FCF ratio for SOLV stock is 88.54x.
- What is the 10Y average EV/FCF ratio for Solventum Corporation (SOLV)?
- The 10Y average EV/FCF ratio for SOLV stock is 88.54x.
- What is the 15Y average EV/FCF ratio for Solventum Corporation (SOLV)?
- The 15Y average EV/FCF ratio for SOLV stock is 88.54x.
- What is the 20Y average EV/FCF ratio for Solventum Corporation (SOLV)?
- The 20Y average EV/FCF ratio for SOLV stock is 88.54x.
Solventum Corporation EV/FCF Ratio History
| DATE | EV/FCF RATIO |
|---|---|
| 2026-02-26 | 339.81x |
| 2026-02-25 | 333.28x |
| 2026-02-24 | 327.46x |
| 2026-02-23 | 324.76x |
| 2026-02-20 | 325.77x |
| 2026-02-19 | 328.12x |
| 2026-02-18 | 332.68x |
| 2026-02-17 | 328.54x |
| 2026-02-13 | 334.93x |
| 2026-02-12 | 336.33x |
| 2026-02-11 | 355.77x |
| 2026-02-10 | 352.15x |
| 2026-02-09 | 343.77x |
| 2026-02-06 | 343.94x |
| 2026-02-05 | 339.95x |
| 2026-02-04 | 338.23x |
| 2026-02-03 | 335.63x |
| 2026-02-02 | 339.70x |
| 2026-01-30 | 339.91x |
| 2026-01-29 | 338.33x |
| 2026-01-28 | 338.61x |
| 2026-01-27 | 342.16x |
| 2026-01-26 | 347.07x |
| 2026-01-23 | 346.72x |
| 2026-01-22 | 351.49x |
| 2026-01-21 | 351.84x |
| 2026-01-20 | 346.89x |
| 2026-01-16 | 348.72x |
| 2026-01-15 | 352.08x |
| 2026-01-14 | 350.72x |
| 2026-01-13 | 350.65x |
| 2026-01-12 | 370.50x |
| 2026-01-09 | 372.08x |
| 2026-01-08 | 370.78x |
| 2026-01-07 | 365.41x |
| 2026-01-06 | 361.63x |
| 2026-01-05 | 353.35x |
| 2026-01-02 | 347.10x |
| 2025-12-31 | 347.87x |
| 2025-12-30 | 351.10x |
| 2025-12-29 | 350.86x |
| 2025-12-26 | 352.15x |
| 2025-12-24 | 351.17x |
| 2025-12-23 | 352.47x |
| 2025-12-22 | 353.28x |
| 2025-12-19 | 356.12x |
| 2025-12-18 | 352.93x |
| 2025-12-17 | 350.36x |
| 2025-12-16 | 352.61x |
| 2025-12-15 | 357.17x |
| 2025-12-12 | 360.99x |
| 2025-12-11 | 360.33x |
| 2025-12-10 | 357.21x |
| 2025-12-09 | 350.93x |
| 2025-12-08 | 359.66x |
| 2025-12-05 | 369.59x |
| 2025-12-04 | 368.99x |
| 2025-12-03 | 368.96x |
| 2025-12-02 | 370.15x |
| 2025-12-01 | 370.04x |
| 2025-11-28 | 368.99x |
| 2025-11-26 | 369.03x |
| 2025-11-25 | 370.78x |
| 2025-11-24 | 362.40x |
| 2025-11-21 | 360.71x |
| 2025-11-20 | 348.82x |
| 2025-11-19 | 341.10x |
| 2025-11-18 | 339.63x |
| 2025-11-17 | 337.17x |
| 2025-11-14 | 335.32x |
| 2025-11-13 | 333.77x |
| 2025-11-12 | 328.90x |
| 2025-11-11 | 329.07x |
| 2025-11-10 | 321.74x |
| 2025-11-07 | 320.79x |
| 2025-11-06 | 302.41x |
| 2025-11-05 | 130.49x |
| 2025-11-04 | 131.56x |
| 2025-11-03 | 131.00x |
| 2025-10-31 | 132.10x |
| 2025-10-30 | 132.39x |
| 2025-10-29 | 132.98x |
| 2025-10-28 | 134.34x |
| 2025-10-27 | 135.60x |
| 2025-10-24 | 134.96x |
| 2025-10-23 | 135.95x |
| 2025-10-22 | 136.53x |
| 2025-10-21 | 136.71x |
| 2025-10-20 | 136.67x |
| 2025-10-17 | 135.82x |
| 2025-10-16 | 134.96x |
| 2025-10-15 | 135.10x |
| 2025-10-14 | 135.02x |
| 2025-10-13 | 134.29x |
| 2025-10-10 | 133.86x |
| 2025-10-09 | 135.39x |
| 2025-10-08 | 136.14x |
| 2025-10-07 | 135.82x |
| 2025-10-06 | 137.75x |
| 2025-10-03 | 138.01x |
| 2025-10-02 | 138.73x |
| 2025-10-01 | 136.87x |
| 2025-09-30 | 136.82x |
| 2025-09-29 | 135.88x |
| 2025-09-26 | 134.88x |
| 2025-09-25 | 133.79x |
| 2025-09-24 | 135.41x |
| 2025-09-23 | 137.29x |
| 2025-09-22 | 137.73x |
| 2025-09-19 | 137.68x |
| 2025-09-18 | 138.45x |
| 2025-09-17 | 138.10x |
| 2025-09-16 | 138.17x |
| 2025-09-15 | 137.07x |
| 2025-09-12 | 137.29x |
| 2025-09-11 | 137.76x |
| 2025-09-10 | 134.70x |
| 2025-09-09 | 136.70x |
| 2025-09-08 | 138.73x |
| 2025-09-05 | 136.49x |
| 2025-09-04 | 136.08x |
| 2025-09-03 | 134.91x |
| 2025-09-02 | 135.41x |
| 2025-08-29 | 136.93x |
| 2025-08-28 | 136.42x |
| 2025-08-27 | 136.69x |
| 2025-08-26 | 136.73x |
| 2025-08-25 | 136.52x |
| 2025-08-22 | 137.48x |
| 2025-08-21 | 135.63x |
| 2025-08-20 | 136.64x |
| 2025-08-19 | 135.95x |
| 2025-08-18 | 134.15x |
| 2025-08-15 | 134.94x |
| 2025-08-14 | 137.06x |
| 2025-08-13 | 138.47x |
| 2025-08-12 | 135.74x |
| 2025-08-11 | 135.46x |
| 2025-08-08 | 137.29x |
| 2025-08-07 | 135.57x |
| 2025-08-06 | 52.11x |
| 2025-08-05 | 52.05x |
| 2025-08-04 | 52.41x |
| 2025-08-01 | 51.73x |
| 2025-07-31 | 51.57x |
| 2025-07-30 | 52.30x |
| 2025-07-29 | 52.56x |
| 2025-07-28 | 52.66x |
| 2025-07-25 | 53.10x |
| 2025-07-24 | 52.73x |
| 2025-07-23 | 52.95x |
| 2025-07-22 | 52.27x |
| 2025-07-21 | 52.01x |
| 2025-07-18 | 52.44x |
| 2025-07-17 | 52.70x |
| 2025-07-16 | 52.32x |
| 2025-07-15 | 52.62x |
| 2025-07-14 | 52.80x |
| 2025-07-11 | 52.67x |
| 2025-07-10 | 53.62x |
| 2025-07-09 | 52.85x |
| 2025-07-08 | 53.25x |
| 2025-07-07 | 53.78x |
| 2025-07-03 | 54.81x |
| 2025-07-02 | 54.69x |
| 2025-07-01 | 54.53x |
| 2025-06-30 | 53.60x |
| 2025-06-27 | 53.43x |
| 2025-06-26 | 53.05x |
| 2025-06-25 | 53.20x |
| 2025-06-24 | 53.21x |
| 2025-06-23 | 52.42x |
| 2025-06-20 | 52.57x |
| 2025-06-18 | 52.14x |
| 2025-06-17 | 52.20x |
| 2025-06-16 | 52.97x |
| 2025-06-13 | 52.67x |
| 2025-06-12 | 52.90x |
| 2025-06-11 | 52.95x |
| 2025-06-10 | 53.47x |
| 2025-06-09 | 53.18x |
| 2025-06-06 | 53.15x |
| 2025-06-05 | 53.39x |
| 2025-06-04 | 53.28x |
| 2025-06-03 | 52.88x |
| 2025-06-02 | 52.36x |
| 2025-05-30 | 52.35x |
| 2025-05-29 | 52.13x |
| 2025-05-28 | 52.14x |
| 2025-05-27 | 52.10x |
| 2025-05-23 | 51.32x |
| 2025-05-22 | 52.16x |
| 2025-05-21 | 52.20x |
| 2025-05-20 | 53.08x |
| 2025-05-19 | 53.57x |
| 2025-05-16 | 52.81x |
| 2025-05-15 | 52.28x |
| 2025-05-14 | 51.47x |
| 2025-05-13 | 52.55x |
| 2025-05-12 | 53.13x |
| 2025-05-09 | 51.05x |
| 2025-05-08 | 23.45x |
| 2025-05-07 | 23.20x |
| 2025-05-06 | 23.20x |
| 2025-05-05 | 23.50x |
| 2025-05-02 | 23.66x |
| 2025-05-01 | 23.23x |
| 2025-04-30 | 23.34x |
| 2025-04-29 | 23.36x |
| 2025-04-28 | 23.33x |
| 2025-04-25 | 23.33x |
| 2025-04-24 | 23.64x |
| 2025-04-23 | 23.29x |
| 2025-04-22 | 23.08x |
| 2025-04-21 | 22.86x |
| 2025-04-17 | 23.37x |
| 2025-04-16 | 23.24x |
| 2025-04-15 | 23.30x |
| 2025-04-14 | 23.70x |
| 2025-04-11 | 23.35x |
| 2025-04-10 | 23.13x |
| 2025-04-09 | 23.87x |
| 2025-04-08 | 22.66x |
| 2025-04-07 | 23.16x |
| 2025-04-04 | 23.35x |
| 2025-04-03 | 24.22x |
| 2025-04-02 | 25.61x |
| 2025-04-01 | 25.55x |
| 2025-03-31 | 25.49x |
| 2025-03-28 | 25.21x |
| 2025-03-27 | 25.37x |
| 2025-03-26 | 25.10x |
| 2025-03-25 | 25.25x |
| 2025-03-24 | 25.09x |
| 2025-03-21 | 25.04x |
| 2025-03-20 | 25.26x |
| 2025-03-19 | 25.55x |
| 2025-03-18 | 25.33x |
| 2025-03-17 | 25.29x |
| 2025-03-14 | 25.08x |
| 2025-03-13 | 24.68x |
| 2025-03-12 | 25.05x |
| 2025-03-11 | 25.45x |
| 2025-03-10 | 25.83x |
| 2025-03-07 | 25.90x |
| 2025-03-06 | 25.42x |
| 2025-03-05 | 25.87x |
| 2025-03-04 | 26.13x |
| 2025-03-03 | 26.38x |
| 2025-02-28 | 26.29x |
| 2025-02-27 | 18.64x |
| 2025-02-26 | 18.73x |
| 2025-02-25 | 18.66x |
| 2025-02-24 | 17.58x |
| 2025-02-21 | 17.09x |
| 2025-02-20 | 17.31x |
| 2025-02-19 | 17.24x |
| 2025-02-18 | 17.29x |
| 2025-02-14 | 17.28x |
| 2025-02-13 | 17.29x |
Showing the most recent 260 of 482 data points. The chart above shows the full history.
Related Metrics
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson